research

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

InvoiceMate Partners with the DFINITY Foundation and Migrates from Hyperledger Fabric to The Internet Computer Blockchain

Source Node:
Time Stamp: October 20, 2023 8:34 AM - Modified On: October 20, 2023 - Published By:
Source Cluster:
Republished By Plato

  Zurich, Switzerland & Dubai, UAE. The DFINITY Foundation, a not-for-profit research and development organization based in Switzerland and a major contributor to the Internet Computer blockchain (ICP), has announced that it has partnered with InvoiceMate. InvoiceMate.tech will migrate from Hyperledger Fabric to the Internet Computer. The DFINITY Foundation will support InvoiceMate in this transition as it becomes an important part of the ICP ecosystem. InvoiceMate is a blockchain & AI-powered invoicing platform that acts as a bridge between SMEs and financing institutions. InvoiceMate leads to easier financial inclusion by

Gate Web3 Startup Announces Exciting New Project Listing: Game Verse

Source Node:
Time Stamp: October 19, 2023 7:20 AM - Modified On: October 19, 2023 - Published By:
Source Cluster:
Republished By Plato

Oct 18th - Gate Web3 Startup, a pioneering platform for innovative blockchain projects, is thrilled to announce the listing of a new project: Game Verse.  The Game Verse airdrop commences on October 18, 2023, at 7:00 UTC and concludes on October 23, 2023, at 7:00 UTC.  Game Verse's latest offering, Sword and Magic World, is a free-to-play MMORPG designed to captivate players with its vast open-world experiences. The game finds its roots in the rich legacy of Game Verse, a trailblazing global GameFi and Metaverse platform. Founded by the stalwarts

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:16 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

HealthCare AI: The Unavoidable Revolution in Modern Medicine

Source Node:
Time Stamp: October 5, 2023 3:39 PM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo

Source Node:
Time Stamp: October 5, 2023 11:22 AM - Modified On: October 5, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionizing Clinical Trials: The Digital Watermarking and AI Duo Clinical trials, the linchpin of medical research, have long been riddled with inefficiencies, from patient recruitment bottlenecks to data management hurdles. As a technology and banking analyst, I've seen how digital solutions can overhaul entire sectors, offering improved productivity and streamlined processes. It's high time that clinical trials get a dose of such digital innovation, and there's a potent combination on the horizon: digital watermarking coupled with Artificial Intelligence (AI). At first glance, one might wonder: how can a technique often

The Convergence of MedTech and Blockchain: Transforming Healthcare

Source Node:
Time Stamp: September 14, 2023 4:39 PM - Modified On: September 14, 2023 - Published By:
Source Cluster:
Republished By Plato

The healthcare industry has witnessed a remarkable transformation driven by technological advancements in recent years. One groundbreaking convergence is the fusion of Medical Technology (MedTech) and blockchain technology. This synergy has the potential to revolutionize healthcare by enhancing data security, interoperability, and patient-centric care. Enhanced Data Security: One of the foremost challenges in healthcare is ensuring the security and privacy of patient data. Medical records contain sensitive information that must be protected from unauthorized access and cyber threats. Blockchain technology offers a robust solution to this problem. Blockchain operates on

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:16 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Swiss WEB3FEST 2023: The Convergence of Web3 Innovation and Collaboration

Source Node:
Time Stamp: August 28, 2023 5:56 AM - Modified On: August 28, 2023 - Published By:
Source Cluster:
Republished By Plato

The Global Web3 Ecosystem is set to unite under the banner of "Switzerland United", an 11-day extravaganza, from September 7th-17th 2023, that combines the forces of the NFT Fest Lugano, NFT Lakeside Unconference and the Swiss WEB3FEST. Key Highlights The Swiss WEB3FEST will be the center of Web3 innovation and collaboration, with over 150 Preeminent speakers, 50+ exhibitors and 80+ captivating topics and side events The Swiss WEB3FEST is the Ecosystem Festival of Crypto Valley and Crypto Oasis and is Co-Hosted by Dfinity aka The Internet Computer The Conference is

Erez Capital Announces Additional Venture Partners

Source Node:
Time Stamp: August 4, 2023 6:52 AM - Modified On: August 4, 2023 - Published By:
Source Cluster:
Republished By Plato

Erez Capital, a emerging venture capital fund investing in disruptive technologies, is thrilled to announce the addition of new Venture Partners. Boston, Massachusetts, United States - August 3rd, 2023 — Erez Capital, a emerging venture capital fund investing in disruptive technologies, is thrilled to announce its addition of 40 Venture Partners to join the fund. These new partners will play an important role in the quickly developing artificial intelligence ecosystem - specifically in the proptech, medtech and fintech sectors. “This fund and its investments will represent the consensus of experts,

Paribus on the Rise

Source Node:
Time Stamp: July 22, 2023 2:39 AM - Modified On: July 22, 2023 - Published By:
Source Cluster:
Republished By Plato

The past few weeks have seen a whirlwind of activity for the team, bridging over to Cardano and raising awareness of Paribus. The upcoming weeks and months will be equally exciting as we are poised to deliver more elements from our roadmap. As more of the circulating PBX supply transitions to Cardano, we’ve been making strides toward getting the token listed on two more decentralized exchanges (DEXs). We’ll be able to announce each one as they launch, so stay tuned to our Discord, Twitter, and Telegram channels for the latest